RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Insulin Resistance
Accession: DOID:9007692
browse the term
Definition: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Synonyms: exact_synonym: Insulin Sensitivity
narrow_synonym: Insulin Resistance Syndrome, Type A
related_synonym: FATTY ACID-BINDING PROTEIN, INTESTINAL, POLYMORPHISM OF; Insulin Resistance, Susceptibility To; Serum hdl cholesterol level, modifier of
primary_id: MESH:D007333 ; RDO:0003504
xref: EFO:0002614
GViewer not supported for the selected species.
G
Acaca
acetyl-CoA carboxylase alpha
treatment
ISO
RGD
PMID:16485039 PMID:26394137
RGD:1625727 RGD:329955565
NCBI chrNW_004624871:4,103,014...4,364,690
Ensembl chrNW_004624871:4,105,067...4,412,325
G
Acacb
acetyl-CoA carboxylase beta
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16485039 PMID:22658938 PMID:26394137
RGD:1625727 RGD:329955565
NCBI chrNW_004624747:12,287,817...12,426,340
Ensembl chrNW_004624747:12,307,541...12,424,897
G
Acp1
acid phosphatase 1
ISO
associated with Obesity
RGD
PMID:17353188
RGD:2313180
NCBI chrNW_004624846:1,735,944...1,748,495
Ensembl chrNW_004624846:1,736,038...1,747,009
G
Acsl1
acyl-CoA synthetase long chain family member 1
ISO
mRNA:decreased expression:subcutaneous adipose tissue
RGD
PMID:16788709
RGD:1625735
NCBI chrNW_004624769:15,503,757...15,584,741
Ensembl chrNW_004624769:15,503,757...15,584,777
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
ISO
associated with Hypertension CTD Direct Evidence: therapeutic
RGD CTD
PMID:16041833 PMID:18931039 PMID:21484566 PMID:21872431 PMID:23089228
RGD:1599150 RGD:8695928 RGD:8695951
NCBI chrNW_004624730:69,941,963...69,959,266
Ensembl chrNW_004624730:69,941,001...69,957,012
G
Adipor1
adiponectin receptor 1
resistance
ISO
associated with Diabetes Mellitus, Type 2;DNA:SNP: :-3881T>C
RGD
PMID:17285539
RGD:1625762
NCBI chrNW_004624807:7,896,508...7,912,088
G
Adipor2
adiponectin receptor 2
treatment
ISO
RGD
PMID:24797033 PMID:30225267
RGD:21406435 RGD:25824940
NCBI chrNW_004624735:11,103,082...11,174,277
Ensembl chrNW_004624735:11,103,076...11,174,337
G
Adm
adrenomedullin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33491863
NCBI chrNW_004624766:2,402,152...2,404,343
Ensembl chrNW_004624766:2,401,769...2,404,446
G
Adora1
adenosine A1 receptor
treatment
ISO
associated with Obesity
RGD
PMID:11703426 PMID:15220221
RGD:1625243 RGD:2313807
NCBI chrNW_004624807:7,674,164...7,705,736
Ensembl chrNW_004624807:7,674,927...7,705,051
G
Adra1b
adrenoceptor alpha 1B
susceptibility
ISO
RGD
PMID:14581480
RGD:1625772
NCBI chrNW_004624733:29,545,870...29,661,954
Ensembl chrNW_004624733:29,545,789...29,662,028
G
Adrb2
adrenoceptor beta 2
ISO
DNA:polymorphisms: :p.R16G CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11510954 PMID:15699455 PMID:19034036
RGD:1598757 RGD:1601125
NCBI chrNW_004624774:8,211,723...8,215,962
Ensembl chrNW_004624774:8,211,984...8,213,240
G
Adrb3
adrenoceptor beta 3
no_association
ISO
DNA:missense mutation:cds:p.W64R rs4994 (human) associated with Obesity;DNA:polymorphism: :p.W64R (human)
RGD
PMID:10421225 PMID:10582543 PMID:17299491
RGD:1559326 RGD:2313158 RGD:5684421
NCBI chrNW_004624780:5,653,499...5,656,138
G
Agtr2
angiotensin II receptor type 2
ISO
protein:increased expression:dorsal root ganglion, neuron
RGD
PMID:22357959
RGD:6903873
NCBI chrNW_004624967:327,627...332,000
Ensembl chrNW_004624967:329,284...330,372
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25734695
NCBI chrNW_004624739:12,939,183...12,987,574
Ensembl chrNW_004624739:12,942,165...12,987,973
G
Ahsg
alpha 2-HS glycoprotein
susceptibility
ISO
protein:increased expression:plasma
RGD
PMID:16567827 PMID:17011519
RGD:1625793 RGD:1625794
NCBI chrNW_004624730:70,149,461...70,156,058
Ensembl chrNW_004624730:70,149,850...70,156,039
G
Akt2
AKT serine/threonine kinase 2
no_association
ISO
DNA:SNPs
RGD
PMID:17327441
RGD:1601155
NCBI chrNW_004624925:262,590...322,440
Ensembl chrNW_004624925:273,881...326,984
G
Aldh2
aldehyde dehydrogenase 2 family member
treatment
ISO
protein:altered expression, altered activity:liver (rat)
RGD
PMID:28688179
RGD:14981582
NCBI chrNW_004624747:20,407,190...20,438,605
Ensembl chrNW_004624747:20,403,717...20,438,690
G
Apln
apelin
ISO
mRNA:increased expression:subcutaneous adipose tissue
RGD
PMID:17594060
RGD:1626170
NCBI chrNW_004624797:8,857,490...8,866,157
Ensembl chrNW_004624797:8,857,070...8,866,329
G
Apoa2
apolipoprotein A2
ISO
RGD
PMID:11246886
RGD:2313957
NCBI chrNW_004624794:164,351...165,676
Ensembl chrNW_004624794:164,370...166,248
G
Apoc1
apolipoprotein C1
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent
RGD
PMID:11723061
RGD:2313951
NCBI chrNW_004624907:1,758,671...1,760,611
Ensembl chrNW_004624907:1,758,696...1,760,611
G
Apoc3
apolipoprotein C3
treatment susceptibility
ISO
RGD
PMID:15007394 PMID:15734841
RGD:1580750 RGD:1601226
NCBI chrNW_004624784:12,244,565...12,246,790
Ensembl chrNW_004624784:12,244,646...12,246,790
G
Ar
androgen receptor
ISO
CTD Direct Evidence: marker/mechanism associated with Polycystic Ovary Syndrome;DNA:repeat: :CAG
CTD RGD
PMID:16793958 PMID:17332526 PMID:21444647
RGD:1601244 RGD:2306773
NCBI chrNW_004624891:3,135,824...3,330,487
Ensembl chrNW_004624891:3,138,848...3,329,459
G
Arg1
arginase 1
ISO
protein:decreased activity:liver (rat)
RGD
PMID:20593143
RGD:4142796
NCBI chrNW_004624753:5,737,720...5,749,313
Ensembl chrNW_004624753:5,737,237...5,752,966
G
Atm
ATM serine/threonine kinase
treatment
ISO
protein:decreased expression:muscle: Associated with human immunodeficiency virus infectious disease, hepatitis C;DNA:SNP:intron: (rs11212617) (human)
RGD
PMID:18534819 PMID:23171036
RGD:126781688 RGD:8693659
NCBI chrNW_004624784:2,933,172...3,080,131
Ensembl chrNW_004624784:2,937,499...3,078,216
G
Bad
BCL2 associated agonist of cell death
ISO
protein:decreased phosphorylation, increased dimerization, increased glycosylation:heart
RGD
PMID:21385329
RGD:10053645
NCBI chrNW_004624767:22,025,721...22,037,283
Ensembl chrNW_004624767:22,026,133...22,037,277
G
Bche
butyrylcholinesterase
ISO
RGD
PMID:17917325
RGD:2306776
NCBI chrNW_004624730:43,793,550...43,849,169
Ensembl chrNW_004624730:43,793,040...43,843,519
G
Bdkrb1
bradykinin receptor B1
ISO
RGD
PMID:17618300 PMID:17988733
RGD:5129214 RGD:5129217
NCBI chrNW_004624734:8,545,707...8,549,846
Ensembl chrNW_004624734:8,548,356...8,549,414
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
ISO
RGD
PMID:25934999
RGD:11085488
NCBI chrNW_004624926:1,189,990...1,197,220
Ensembl chrNW_004624926:1,190,072...1,196,076
G
C1r
complement C1r
ISO
protein:increased expression:adipocyte
RGD
PMID:17244723
RGD:1600551
NCBI chrNW_004624860:3,675,926...3,684,598
Ensembl chrNW_004624860:3,676,252...3,684,406
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18615583
NCBI chrNW_004624828:3,773,816...3,798,077
Ensembl chrNW_004624828:3,770,221...3,797,946
G
Capn10
calpain 10
ISO
DNA:SNP:intron:rs3792267 (human)
RGD
PMID:11018080
RGD:7247736
NCBI chrNW_004624847:4,911,052...4,922,549
Ensembl chrNW_004624847:4,911,737...4,922,192
G
Casp8
caspase 8
ISO
RGD
PMID:29748970
RGD:13782289
NCBI chrNW_004624899:427,064...450,931
Ensembl chrNW_004624899:424,363...451,087
G
Cat
catalase
ISO
associated with Obesity
RGD
PMID:19188683
RGD:5130761
NCBI chrNW_004624767:12,680,940...12,715,468
Ensembl chrNW_004624767:12,680,953...12,715,739
G
Cblb
Cbl proto-oncogene B
ISO
RGD
PMID:17601987
RGD:2314038
NCBI chrNW_004624731:43,803,743...44,018,682
Ensembl chrNW_004624731:43,803,768...44,015,870
G
Cd163
CD163 molecule
exacerbates
ISO
associated with hepatitis C, human immunodeficiency virus infectious disease;protein:increased expression:blood plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:26554542 PMID:29035695
RGD:149735574
NCBI chrNW_004624860:3,976,746...4,000,349
Ensembl chrNW_004624860:3,975,747...4,000,349
G
Cd36
CD36 molecule (CD36 blood group)
ISO
associated with Diabetes Mellitus, Type 2 CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11175782 PMID:12923231 PMID:14640889 PMID:15231693 PMID:25477422
RGD:11040926 RGD:11041132 RGD:2307217 RGD:68930
NCBI chrNW_004624739:29,341,620...29,441,232
Ensembl chrNW_004624739:29,407,568...29,441,333
G
Cd40
CD40 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29035695
NCBI chrNW_004624790:8,475,640...8,485,927
Ensembl chrNW_004624790:8,476,158...8,485,856
G
Cd68
CD68 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29035695
NCBI chrNW_004624786:10,195,337...10,197,963
G
Cers1
ceramide synthase 1
ameliorates
ISO
RGD
PMID:30605666
RGD:156431060
NCBI chrNW_004624908:1,937,007...1,949,780
Ensembl chrNW_004624908:1,941,393...1,949,760
G
Cnr1
cannabinoid receptor 1
ISO
associated with Obesity
RGD
PMID:19553924
RGD:2314662
NCBI chrNW_004624799:6,100,709...6,126,530
Ensembl chrNW_004624799:6,101,728...6,126,520
G
Coq2
coenzyme Q2, polyprenyltransferase
ISO
associated with obesity
RGD
PMID:26296322
RGD:10755343
NCBI chrNW_004624900:272,440...288,090
Ensembl chrNW_004624900:272,404...288,675
G
Cpb2
carboxypeptidase B2
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression, increased activity:plasma
RGD
PMID:11836301
RGD:2313645
NCBI chrNW_004624748:8,850,128...8,927,986
Ensembl chrNW_004624748:8,849,900...8,928,853
G
Cpe
carboxypeptidase E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15358678
NCBI chrNW_004624758:11,464,418...11,603,660
Ensembl chrNW_004624758:11,463,012...11,604,224
G
Ctf1
cardiotrophin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21803294
NCBI chrNW_004624782:13,976,308...13,979,327
G
Dgat2
diacylglycerol O-acyltransferase 2
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004624817:1,386,876...1,418,129
Ensembl chrNW_004624817:1,386,764...1,418,300
G
Dio2
iodothyronine deiodinase 2
ISO
DNA:SNP: :rs225014, p.T92A (human)
RGD
PMID:11872697
RGD:2313698
NCBI chrNW_004624734:21,787,705...21,802,096
G
Drd1
dopamine receptor D1
ISO
associated with Obesity;protein:increased serine phosphorylation:renal proximal tubule
RGD
PMID:15798088
RGD:2302119
NCBI chrNW_004624733:14,517,540...14,522,173
Ensembl chrNW_004624733:14,518,146...14,520,905
G
Ech1
enoyl-CoA hydratase 1
treatment
ISO
RGD
PMID:31961704
RGD:21408561
NCBI chrNW_004624794:12,196,402...12,203,674
Ensembl chrNW_004624794:12,195,385...12,203,606
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22238402
NCBI chrNW_004624740:584,133...713,205
Ensembl chrNW_004624740:589,606...713,271
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
ISO
ClinVar Annotator: match by term: Insulin resistance, susceptibility to
ClinVar
PMID:10480624 PMID:11739459 PMID:14671192 PMID:14988267 PMID:15001634 PMID:15126519 PMID:16025115 PMID:16607460 PMID:16968801 PMID:18950909 PMID:20981035 PMID:25741868 PMID:27238374 PMID:28492532 PMID:29979387 PMID:35738466 More...
NCBI chrNW_004624753:5,918,005...5,983,480
Ensembl chrNW_004624753:5,917,689...5,982,308
G
F7
coagulation factor VII
severity
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human)
RGD
PMID:9187410
RGD:2312406
NCBI chrNW_004624793:780,057...788,105
Ensembl chrNW_004624793:780,059...788,095
G
Fabp3
fatty acid binding protein 3
severity
ISO
RGD
PMID:16249436
RGD:1578459
NCBI chrNW_004624764:14,698,062...14,705,379
Ensembl chrNW_004624764:14,698,062...14,705,972
G
Fanca
FA complementation group A
ISO
RGD
PMID:22482891
RGD:11046266
NCBI chrNW_004624746:206,069...253,473
Ensembl chrNW_004624746:215,193...252,569
G
Fancc
FA complementation group C
ISO
RGD
PMID:22482891
RGD:11046266
NCBI chrNW_004624753:16,566,864...16,811,438
G
Fas
Fas cell surface death receptor
treatment
ISO
associated with hypothalamic disease
RGD
PMID:29522769
RGD:13792596
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
G
Fasn
fatty acid synthase
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004624801:10,910,022...10,926,505
Ensembl chrNW_004624801:10,909,647...10,927,547
G
Fgf19
fibroblast growth factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28673684
NCBI chrNW_004624767:17,434,501...17,439,351
Ensembl chrNW_004624767:17,432,358...17,438,173
G
Fis1
fission, mitochondrial 1
ISO
protein:increased expression:liver (rat)
RGD
PMID:24663492
RGD:12453042
NCBI chrNW_004624740:16,052,777...16,056,438
Ensembl chrNW_004624740:16,052,820...16,057,098
G
Foxc2
forkhead box C2
ISO
DNA:polymorphism:5'ut:-512C>T
RGD
PMID:12453913
RGD:1601219
NCBI chrNW_004624746:2,632,547...2,634,867
Ensembl chrNW_004624746:2,632,619...2,634,085
G
Foxo1
forkhead box O1
ISO
mRNA:increased expression:adipose tissue:
RGD
PMID:16041833
RGD:1599150
NCBI chrNW_004624748:1,413,754...1,529,646
Ensembl chrNW_004624748:1,413,983...1,529,992
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
ISO
associated with diabetes mellitus;DNA:SNP: :rs9939609 (human) mRNA, protein:increased expression:liver DNA:SNPs, haplotype: :rs1121980, rs1558902, rs9939609 (human) associated with obesity;DNA:SNP:intron:rs17817449 (human)
RGD
PMID:20075932 PMID:21919686 PMID:30273662 PMID:35945320
RGD:329812018 RGD:329812040 RGD:329853775 RGD:329951016
NCBI chrNW_004624757:2,675,810...3,081,751
Ensembl chrNW_004624757:2,675,671...3,080,480
G
Fxn
frataxin
ISO
DNA:repeats:intron:GAA (human)
RGD
PMID:10969848
RGD:2307049
NCBI chrNW_004624736:4,027,054...4,047,881
Ensembl chrNW_004624736:4,027,354...4,047,854
G
G6pd
glucose-6-phosphate dehydrogenase
ISO
associated with Obesity;protein:increased expression:pancreas
RGD
PMID:23015612
RGD:10449129
NCBI chrNW_004624946:989,376...1,001,787
Ensembl chrNW_004624946:986,107...1,001,955
G
Gck
glucokinase
ISO
protein:increased expression:pancreatic islet
RGD
PMID:19039094
RGD:7488970
NCBI chrNW_004624740:7,844,496...7,885,900
Ensembl chrNW_004624740:7,852,390...7,886,758
G
Gfpt1
glutamine--fructose-6-phosphate transaminase 1
ISO
RGD
PMID:11118009
RGD:1625423
NCBI chrNW_004624762:3,943,074...4,016,090
Ensembl chrNW_004624762:3,942,972...4,010,498
G
Gnas
GNAS complex locus
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17062894
NCBI chrNW_004624741:25,138,678...25,197,194
Ensembl chrNW_004624741:25,183,329...25,196,880
G
Gnb3
G protein subunit beta 3
ISO
DNA:polymorphism: :825C>T (human)
RGD
PMID:12624279
RGD:1580411
NCBI chrNW_004624860:3,509,185...3,515,025
Ensembl chrNW_004624860:3,509,397...3,515,352
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004624737:34,198,773...34,268,815
Ensembl chrNW_004624737:34,198,518...34,265,192
G
Gpr17
G protein-coupled receptor 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34144038
NCBI chrNW_004624732:14,115,267...14,129,714
Ensembl chrNW_004624732:14,115,325...14,128,169
G
Gpx3
glutathione peroxidase 3
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma
CTD RGD
PMID:19270708 PMID:24361363
RGD:401827920
NCBI chrNW_004624733:40,957,895...40,963,469
Ensembl chrNW_004624733:40,957,999...40,962,993
G
Grk2
G protein-coupled receptor kinase 2
ISO
RGD
PMID:15994203
RGD:1625791
NCBI chrNW_004624767:19,212,218...19,231,218
Ensembl chrNW_004624767:19,210,965...19,231,082
G
Gsta4
glutathione S-transferase alpha 4
ISO
mRNA:decreased expression:omental fat pad, subcutaneous adipose tissue (human)
RGD
PMID:20150287
RGD:5687771
NCBI chrNW_004624850:201,119...217,302
Ensembl chrNW_004624850:201,592...216,680
G
Gys1
glycogen synthase 1
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:missense mutation:exon:p.M416V (human)
RGD
PMID:9267990
RGD:2313176
NCBI chrNW_004624832:5,029,272...5,044,679
Ensembl chrNW_004624832:5,029,057...5,045,190
G
Hamp
hepcidin antimicrobial peptide
ISO
mRNA:decreased expression:liver
RGD
PMID:17350134
RGD:1601515
NCBI chrNW_004624794:8,257,760...8,259,243
Ensembl chrNW_004624794:8,257,760...8,259,264
G
Hmga1
high mobility group AT-hook 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23512162
NCBI chrNW_004624754:22,888,052...22,900,685
Ensembl chrNW_004624754:22,892,226...22,898,807
G
Hmox1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:muscle:defective protection against oxidative stress
CTD RGD
PMID:12941774 PMID:18375438 PMID:19171794
RGD:1601621
NCBI chrNW_004624750:341,699...346,005
Ensembl chrNW_004624750:342,146...345,887
G
Hnf1a
HNF1 homeobox A
ISO
ClinVar Annotator: match by term: SERUM HDL CHOLESTEROL LEVEL, MODIFIER OF
ClinVar
PMID:8945470 PMID:9112026 PMID:9287053 PMID:9604876 PMID:10333057 PMID:10588527 PMID:10634407 PMID:10852449 PMID:12627330 PMID:12675668 PMID:12788852 PMID:15031772 PMID:15761192 PMID:15928245 PMID:16963153 PMID:17033837 PMID:17192490 PMID:17407072 PMID:17425917 PMID:17440016 PMID:17573900 PMID:17937063 PMID:18332101 PMID:18498634 PMID:18811724 PMID:20031592 PMID:24728327 PMID:24933231 PMID:25741868 PMID:26467025 PMID:27130141 PMID:28492532 PMID:29895593 PMID:31109344 PMID:33363396 PMID:35328643 More...
NCBI chrNW_004624747:12,717,713...12,746,040
Ensembl chrNW_004624747:12,717,707...12,746,724
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21786805
NCBI chrNW_004624807:2,260,702...2,293,962
Ensembl chrNW_004624807:2,261,006...2,293,804
G
Hspd1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:18948349
RGD:10402862
NCBI chrNW_004624889:2,736,727...2,746,333
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
associated with Peripheral Vascular Diseases
RGD
PMID:17062970
RGD:1624367
NCBI chrNW_004624748:8,154,288...8,223,226
Ensembl chrNW_004624748:8,155,107...8,223,259
G
Icam1
intercellular adhesion molecule 1
ISO
associated with Obesity;protein:increased secretion:plasma (human) protein:increased expression:serum
RGD
PMID:11782876 PMID:19394054
RGD:1625753 RGD:2313467
NCBI chrNW_004624828:2,432,584...2,451,997
Ensembl chrNW_004624828:2,432,550...2,453,071
G
Igf2bp2
insulin like growth factor 2 mRNA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chrNW_004624730:70,914,763...71,061,313
Ensembl chrNW_004624730:70,914,804...71,059,642
G
Igfals
insulin like growth factor binding protein acid labile subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17726072
NCBI chrNW_004624913:460,862...464,457
Ensembl chrNW_004624913:458,844...465,193
G
Igfbp2
insulin like growth factor binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17259371 PMID:22537059
RGD:1626479
NCBI chrNW_004624823:8,460,968...8,486,495
Ensembl chrNW_004624823:8,460,553...8,486,495
G
Igfbp3
insulin like growth factor binding protein 3
ISO
RGD
PMID:17237715
RGD:2313762
NCBI chrNW_004624740:6,878,818...6,886,512
Ensembl chrNW_004624740:6,877,348...6,886,512
G
Igfbp6
insulin like growth factor binding protein 6
ISO
human transgene overexpressed in mouse brain
RGD
PMID:15889232
RGD:2301717
NCBI chrNW_004624904:1,153,890...1,159,095
Ensembl chrNW_004624904:1,154,882...1,159,209
G
Igfbp7
insulin like growth factor binding protein 7
ISO
protein:increased expression:serum associated with metabolic dysfunction-associated steatotic liver disease
RGD
PMID:16873698 PMID:31397492
RGD:1626516 RGD:401960873
NCBI chrNW_004624761:12,318,571...12,387,489
Ensembl chrNW_004624761:12,318,006...12,387,582
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11533494 PMID:19073766 PMID:29036520
RGD:10045961 RGD:7495768
NCBI chrNW_004624780:922,524...978,687
Ensembl chrNW_004624780:923,744...970,519
G
Il18
interleukin 18
treatment
ISO
associated with Graves Disease
RGD
PMID:16732281 PMID:23257837
RGD:14695532 RGD:8655938
NCBI chrNW_004624784:7,294,286...7,312,959
Ensembl chrNW_004624784:7,294,183...7,304,687
G
Il1b
interleukin 1 beta
treatment
ISO
associated with Obesity;mRNA:increased expression:adipose tissue associated with hypothalamic disease
RGD
PMID:16865359 PMID:29522769
RGD:13792596 RGD:1626632
NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760
G
Il6
interleukin 6
ISO
mRNA:increased expression:islet of Langerhans associated with Diabetes Mellitus, Experimental; protein:increased expression:extracellular space (rat)
RGD
PMID:19328014 PMID:21826222
RGD:10402828 RGD:2307252
NCBI chrNW_004624739:7,957,709...7,963,414
Ensembl chrNW_004624739:7,957,674...7,962,318
G
Il6r
interleukin 6 receptor
ISO
protein:decreased expression:serum
RGD
PMID:14962155
RGD:1625431
NCBI chrNW_004624885:2,910,367...2,946,916
Ensembl chrNW_004624885:2,910,112...2,946,886
G
Il7
interleukin 7
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20376352
NCBI chrNW_004624744:12,562,536...12,604,037
Ensembl chrNW_004624744:12,567,661...12,604,074
G
Inppl1
inositol polyphosphate phosphatase like 1
ISO
associated with Metabolic Syndrome X
RGD
PMID:12453826 PMID:17327370
RGD:2312440 RGD:2312442
NCBI chrNW_004624817:4,779,875...4,794,644
Ensembl chrNW_004624817:4,779,057...4,793,732
G
Ins
insulin
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:3322910 PMID:11522680 PMID:24648896 PMID:25796170 PMID:33651899
RGD:2311112
NCBI chrNW_004624767:14,999,088...15,000,035
Ensembl chrNW_004624767:14,999,088...15,000,035
G
Insr
insulin receptor
disease_progression treatment
ISO
mRNA, protein:decreased expression:liver (rat) ClinVar Annotator: match by term: Insulin resistance | ClinVar Annotator: match by term: Insulin-resistance syndrome type A
RGD ClinVar
PMID:1314826 PMID:1644241 PMID:1890161 PMID:1963473 PMID:1971035 PMID:2002058 PMID:2040394 PMID:2121734 PMID:2203761 PMID:2211730 PMID:2365819 PMID:2460770 PMID:2544997 PMID:2544998 PMID:2662406 PMID:2859121 PMID:2983222 PMID:3283938 PMID:3384956 PMID:3510919 PMID:6339538 PMID:7042734 PMID:7657032 PMID:8096518 PMID:8202531 PMID:8257688 PMID:8288049 PMID:8314008 PMID:8432414 PMID:8900242 PMID:10084586 PMID:10933564 PMID:11463381 PMID:13302174 PMID:15161766 PMID:19135752 PMID:22775283 PMID:23538485 PMID:23705494 PMID:24033266 PMID:25741868 PMID:26300412 PMID:26874853 PMID:27840822 PMID:27896077 PMID:28492532 PMID:28765322 PMID:30663027 PMID:31989990 PMID:35000900 More...
RGD:10403037 RGD:11529553
NCBI chrNW_004624828:345,135...485,856
Ensembl chrNW_004624828:345,135...486,184
G
Irs1
insulin receptor substrate 1
ISO
ClinVar Annotator: match by term: Insulin resistance, susceptibility to
ClinVar
PMID:1311924 PMID:7623569 PMID:8104271 PMID:8647950 PMID:10084586 PMID:10430617 PMID:10591678 PMID:10843189 PMID:12843189 PMID:14671192 PMID:14707024 PMID:15240653 More...
NCBI chrNW_004624843:1,113,075...1,178,859
Ensembl chrNW_004624843:1,120,974...1,178,859
G
Irs2
insulin receptor substrate 2
ISO
DNA:polymorphism:exon:G1057D CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15811564 PMID:25808216
RGD:1625025
NCBI chrNW_004624793:2,615,092...2,636,835
Ensembl chrNW_004624793:2,614,589...2,636,947
G
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29035695
NCBI chrNW_004624782:14,316,505...14,367,841
Ensembl chrNW_004624782:14,318,499...14,367,922
G
Kcnj11
potassium inwardly rectifying channel subfamily J member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032110
NCBI chrNW_004624766:9,012,166...9,015,269
Ensembl chrNW_004624766:9,013,225...9,014,397
G
Kcnmb1
potassium calcium-activated channel subfamily M regulatory beta subunit 1
ISO
mRNA, protein:decreased expression:aorta, mesenteric artery
RGD
PMID:21425425
RGD:10412047
NCBI chrNW_004624733:19,582,646...19,593,581
Ensembl chrNW_004624733:19,582,489...19,597,722
G
Klf11
KLF transcription factor 11
ISO
RGD
PMID:18505768
RGD:2311539
NCBI chrNW_004624865:5,023,074...5,031,347
G
Klf14
KLF transcription factor 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29632379
NCBI chrNW_004624783:5,593,860...5,595,803
Ensembl chrNW_004624783:5,593,860...5,594,855
G
Klk1
kallikrein 1
ISO
RGD
PMID:17272402
RGD:1641794
NCBI chrNW_004624832:3,869,255...3,873,350
Ensembl chrNW_004624832:3,868,465...3,873,290
G
Lep
leptin
ISO
associated with Obesity CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:plasma DNA:nonsense mutation:cds:
RGD CTD
PMID:10753628 PMID:11342529 PMID:19296906 PMID:19419916 PMID:23800849 PMID:24150608 PMID:29650965 More...
RGD:2311127 RGD:5128697 RGD:8549777
NCBI chrNW_004624783:7,708,820...7,721,610
Ensembl chrNW_004624783:7,708,588...7,721,727
G
Lepr
leptin receptor
ISO
associated with Obesity;DNA:missense mutation:CDS:p.K656N (human) CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:missense mutation:CDS:p.K656N (human)
RGD CTD
PMID:18413223 PMID:18632178 PMID:19452630 PMID:20567778 PMID:23154293 PMID:25367288 PMID:28611668 PMID:29988851 PMID:30689673 More...
RGD:13432147 RGD:2311138 RGD:2311142
NCBI chrNW_004624742:29,221,742...29,313,273
Ensembl chrNW_004624742:29,223,392...29,337,049
G
Lipc
lipase C, hepatic type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15504970
NCBI chrNW_004624781:13,342,469...13,468,120
Ensembl chrNW_004624781:13,342,357...13,455,055
G
Lmna
lamin A/C
ISO
ClinVar Annotator: match by term: Insulin-resistance syndrome type A
ClinVar
PMID:15919811 PMID:16478798 PMID:20848652 PMID:23785128 PMID:24033266 PMID:25637381 PMID:25741868 PMID:28492532 PMID:28663758 PMID:33661429 More...
NCBI chrNW_004624885:1,423,563...1,466,657
Ensembl chrNW_004624885:1,447,395...1,467,554
G
LOC101719398
serotransferrin
ISO
protein:increased expression:plasma
RGD
PMID:17350134
RGD:1601515
NCBI chrNW_004624730:10,078,165...10,109,349
G
LOC101724787
vitamin D 25-hydroxylase
ISO
DNA:SNP:CDS: rs12794714|rs10766197 (human)
RGD
PMID:34906413
RGD:401900724
NCBI chrNW_004624766:6,667,662...6,678,045
Ensembl chrNW_004624766:6,667,234...6,677,992
G
Lpin1
lipin 1
ISO
RGD
PMID:17563064
RGD:1641822
NCBI chrNW_004624865:4,220,047...4,258,014
Ensembl chrNW_004624865:4,219,081...4,258,448
G
Lpl
lipoprotein lipase
ISO
RGD
PMID:18952837
RGD:2313300
NCBI chrNW_004624758:15,652,553...15,680,107
Ensembl chrNW_004624758:15,651,992...15,680,762
G
Lta
lymphotoxin alpha
no_association
ISO
DNA:polymorphism
RGD
PMID:9245742
RGD:1625035
NCBI chrNW_004624754:24,626,930...24,628,412
Ensembl chrNW_004624754:24,627,318...24,628,182
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
associated with polycystic ovary syndrome
RGD
PMID:23349861
RGD:13800789
NCBI chrNW_004624782:13,150,824...13,158,327
Ensembl chrNW_004624782:13,152,039...13,159,113
G
Mc4r
melanocortin 4 receptor
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:liver (rat) DNA:nonsense mutation:cds:p.K314X (rat)
CTD RGD
PMID:18454146 PMID:24400148 PMID:35945320
RGD:13825242 RGD:329951016
NCBI chrNW_004624792:5,865,902...5,867,498
Ensembl chrNW_004624792:5,866,119...5,867,120
G
Metrnl
meteorin like, glial cell differentiation regulator
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30213948
NCBI chrNW_004624801:11,701,821...11,715,693
Ensembl chrNW_004624801:11,701,778...11,715,383
G
Mettl14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chrNW_004624867:5,508,847...5,533,395
Ensembl chrNW_004624867:5,508,886...5,533,395
G
Mfn2
mitofusin 2
treatment
ISO
RGD
PMID:24715199
RGD:13204838
NCBI chrNW_004624818:1,041,371...1,065,061
Ensembl chrNW_004624818:1,041,369...1,065,023
G
Mif
macrophage migration inhibitory factor
ISO
protein:increased expression:plasma
RGD
PMID:12552367
RGD:1641955
NCBI chrNW_004624747:10,307,826...10,308,649
Ensembl chrNW_004624747:10,303,919...10,308,821
G
Mlxipl
MLX interacting protein like
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004624740:14,150,425...14,187,687
Ensembl chrNW_004624740:14,168,238...14,187,264
G
Mlycd
malonyl-CoA decarboxylase
treatment
ISO
RGD
PMID:26394137
RGD:329955565
NCBI chrNW_004624746:3,604,773...3,619,790
Ensembl chrNW_004624746:3,604,773...3,619,775
G
Mrc1
mannose receptor C-type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29035695
NCBI chrNW_004624796:10,041,483...10,184,458
Ensembl chrNW_004624796:10,145,610...10,180,671 Ensembl chrNW_004624796:10,145,610...10,180,671
G
Nampt
nicotinamide phosphoribosyltransferase
ISO
associated with Polycystic Ovary Syndrome;protein:increased expression:serum
RGD
PMID:17582143
RGD:1642341
NCBI chrNW_004624739:23,411,478...23,444,590
Ensembl chrNW_004624739:23,411,488...23,442,359
G
Neil1
nei like DNA glycosylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21285402
NCBI chrNW_004624894:282,799...287,265
Ensembl chrNW_004624894:282,695...288,058
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
associated with obesity; protein:decreased expression:hepatocyte: CTD Direct Evidence: therapeutic
RGD CTD
PMID:32102936 PMID:33933676
RGD:21201281
NCBI chrNW_004624787:14,355,330...14,381,353
Ensembl chrNW_004624787:14,355,791...14,381,251
G
Nlrp3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chrNW_004624937:564,191...584,470
G
Nos2
nitric oxide synthase 2
ISO
mRNA, protein:increased expression:retroperitoneum, adipose tissue (rat)
RGD
PMID:21846719 PMID:22023455
RGD:5509041 RGD:5509075
NCBI chrNW_004624786:491,944...530,427
Ensembl chrNW_004624786:489,311...528,271
G
Nos3
nitric oxide synthase 3
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic protein:decreased expression:serum
RGD CTD
PMID:11457755 PMID:12716763 PMID:12947532 PMID:18298918 PMID:19008412 PMID:28946194 More...
RGD:13450950 RGD:2292098
NCBI chrNW_004624800:5,600,215...5,619,020
Ensembl chrNW_004624800:5,600,212...5,619,004
G
Nppb
natriuretic peptide B
ISO
associated with Obesity and Hypertension;protein:decreased expression:serum
RGD
PMID:17392814
RGD:1642192
NCBI chrNW_004624818:1,139,776...1,141,010
G
Nr1h4
nuclear receptor subfamily 1 group H member 4
susceptibility
ISO
RGD
PMID:16557297
RGD:1625076
NCBI chrNW_004624750:7,222,306...7,303,809
Ensembl chrNW_004624750:7,219,251...7,303,834
G
Nr4a1
nuclear receptor subfamily 4 group A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17785466
NCBI chrNW_004624816:271,345...288,265
Ensembl chrNW_004624816:267,303...293,227
G
Nr4a3
nuclear receptor subfamily 4 group A member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17785466
NCBI chrNW_004624825:1,098,915...1,141,373
Ensembl chrNW_004624825:1,097,432...1,141,446
G
Nus1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33812996
NCBI chrNW_004624798:12,132,570...12,154,252
Ensembl chrNW_004624798:12,130,569...12,154,314
G
Parl
presenilin associated rhomboid like
ISO
mRNA:decreased expression:gastrocnemius (rat)
RGD
PMID:19859837
RGD:12880442
NCBI chrNW_004624730:72,642,828...72,683,820
Ensembl chrNW_004624730:72,642,925...72,683,820
G
Pdx1
pancreatic and duodenal homeobox 1
ISO
protein:increased expression:pancreatic duct (rat) associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:decreased expression:pancreatic islet (mouse)
RGD
PMID:16046294 PMID:18288891
RGD:2311222 RGD:2311223
NCBI chrNW_004624776:10,591,855...10,596,738
Ensembl chrNW_004624776:10,591,855...10,596,676
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism associated with Pre-Eclampsia;protein:increased tyrosine phosphorylation:placenta
CTD RGD
PMID:10426374 PMID:14714311 PMID:16332940 PMID:17283057
RGD:1625211 RGD:1625212 RGD:1625262
NCBI chrNW_004624815:1,290,106...1,376,961
Ensembl chrNW_004624815:1,289,997...1,369,610
G
Pklr
pyruvate kinase L/R
treatment
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:12958186 PMID:26394137
RGD:1625583 RGD:329955565
NCBI chrNW_004624885:2,261,850...2,272,175
Ensembl chrNW_004624885:2,264,928...2,272,171
G
Pla2g1b
phospholipase A2 group IB
susceptibility
ISO
RGD
PMID:12376327
RGD:1302550
NCBI chrNW_004624747:13,322,095...13,329,928
Ensembl chrNW_004624747:13,322,675...13,329,926
G
Plac8
placenta associated 8
ISO
associated with obesity
RGD
PMID:26296322
RGD:10755343
NCBI chrNW_004624900:134,075...157,982
Ensembl chrNW_004624900:133,889...158,050
G
Plekhs1
pleckstrin homology domain containing S1
ISO
associated with obesity;
RGD
PMID:27523322
RGD:11532750
NCBI chrNW_004624737:32,810,663...32,835,211
Ensembl chrNW_004624737:32,810,212...32,835,258
G
Plin2
perilipin 2
ISO
associated with Obesity
RGD
PMID:17484887
RGD:1625752
NCBI chrNW_004624736:23,114,149...23,122,634
Ensembl chrNW_004624736:23,111,265...23,122,193
G
Pltp
phospholipid transfer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12754275
NCBI chrNW_004624790:8,673,212...8,686,094
Ensembl chrNW_004624790:8,673,089...8,685,942
G
Pmch
pro-melanin concentrating hormone
ISO
RGD
PMID:16002548
RGD:1642484
NCBI chrNW_004624750:6,109,542...6,110,834
Ensembl chrNW_004624750:6,109,284...6,111,547
G
Pon1
paraoxonase 1
ISO
DNA:SNP:CDS:p.L55M (human), LL genotype (P < 0.001)
RGD
PMID:11788650
RGD:1642617
NCBI chrNW_004624813:1,953,796...1,979,846
Ensembl chrNW_004624813:1,949,614...1,979,882
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:16168052 PMID:19322024 PMID:21324916
RGD:5683642
NCBI chrNW_004624752:3,646,499...3,702,553
Ensembl chrNW_004624752:3,650,922...3,701,672
G
Ppard
peroxisome proliferator activated receptor delta
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent associated with Obesity
RGD
PMID:14676330 PMID:19818749
RGD:2313780 RGD:2324897
NCBI chrNW_004624754:22,021,465...22,084,320
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: therapeutic DNA:nonsense mutation
CTD RGD
PMID:12118251 PMID:16168052 PMID:21354099 PMID:21484566
RGD:1601446
NCBI chrNW_004624956:84,673...207,176
Ensembl chrNW_004624956:83,842...149,481
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
ISO
DNA:missense mutation:cds:p.G482S rs8192678 (human) mRNA:decreased expression:liver (rat)
RGD
PMID:22658649 PMID:23449621 PMID:26394137
RGD:329955565 RGD:7241821 RGD:7242170
NCBI chrNW_004624755:7,826,219...8,460,746
Ensembl chrNW_004624755:8,375,596...8,465,297
G
Ppargc1b
PPARG coactivator 1 beta
treatment
ISO
RGD
PMID:16896940 PMID:26394137
RGD:1642499 RGD:329955565
NCBI chrNW_004624774:9,056,138...9,178,645
Ensembl chrNW_004624774:9,056,322...9,174,388
G
Ppp1r3a
protein phosphatase 1 regulatory subunit 3A
ISO
ClinVar Annotator: match by term: Insulin resistance, susceptibility to
ClinVar
PMID:7581368 PMID:25741868
NCBI chrNW_004624827:5,543,497...5,581,779
Ensembl chrNW_004624827:5,543,420...5,581,847
G
Prdx3
peroxiredoxin 3
ISO
associated with obesity;
RGD
PMID:27523322
RGD:11532750
NCBI chrNW_004624737:27,625,120...27,635,221
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism associated with Obesity
CTD RGD
PMID:19934007 PMID:22231922
RGD:6484545
NCBI chrNW_004624759:14,143,439...14,174,971
Ensembl chrNW_004624759:14,142,956...14,171,718
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
susceptibility
ISO
DNA:SNPs CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16567511 PMID:19934007
RGD:1625266
NCBI chrNW_004624862:3,443,720...3,496,078
Ensembl chrNW_004624862:3,450,078...3,496,142
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29367455
NCBI chrNW_004624870:3,552,608...3,575,461
Ensembl chrNW_004624870:3,552,745...3,574,880
G
Prkcb
protein kinase C beta
ISO
RGD
PMID:12665248
RGD:1625515
NCBI chrNW_004624782:8,974,995...9,287,609
Ensembl chrNW_004624782:8,974,765...9,287,702
G
Prkcd
protein kinase C delta
ISO
associated with Obesity;protein:increased activity:adipocyte protein:altered localization:nucleus
RGD
PMID:12217885 PMID:15507533
RGD:1642527 RGD:729667
NCBI chrNW_004624822:4,035,819...4,062,907
Ensembl chrNW_004624822:4,033,130...4,059,555
G
Prkcq
protein kinase C theta
ISO
associated with Obesity;protein:decreased expression:skeletal muscle protein:altered localization:skeletal muscle
RGD
PMID:9000691 PMID:10923637
RGD:1625603 RGD:1625604
NCBI chrNW_004624775:1,419,596...1,543,805
Ensembl chrNW_004624775:1,419,509...1,502,064
G
Prkcz
protein kinase C zeta
ISO
protein::skeletal muscle:reduced response to insulin in obese and diabetic subjects
RGD
PMID:12882908
RGD:1642650
NCBI chrNW_004624818:7,758,192...7,846,950
Ensembl chrNW_004624818:7,759,770...7,847,208
G
Prkd1
protein kinase D1
susceptibility
ISO
human gene in a mouse model
RGD
PMID:25173922
RGD:307436943
NCBI chrNW_004624820:2,408,562...2,726,199
Ensembl chrNW_004624820:2,408,360...2,726,606
G
Prl
prolactin
ISO
associated with Hyperprolactinemia
RGD
PMID:3888755
RGD:1642560
NCBI chrNW_004624756:4,585,542...4,593,285
G
Prmt7
protein arginine methyltransferase 7
ISO
ClinVar Annotator: match by term: Insulin resistance
ClinVar
PMID:25741868 PMID:26437029 PMID:27718516 PMID:28492532 PMID:28902392
NCBI chrNW_004624746:17,949,443...18,017,344
Ensembl chrNW_004624746:17,948,085...18,001,259
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism protein:increased activity:liver (human) protein:increased expression, decreased acetylation:liver
CTD RGD
PMID:18303120 PMID:18385463 PMID:24367090
RGD:127285595 RGD:2292521
NCBI chrNW_004624791:13,975,235...14,056,900
G
Ptgds
prostaglandin D2 synthase
susceptibility
ISO
RGD
PMID:15970590
RGD:1642581
NCBI chrNW_004624760:920,292...923,174
Ensembl chrNW_004624760:920,877...923,283
G
Ptgis
prostaglandin I2 synthase
ISO
protein:decreased activity:aorta (rat)
RGD
PMID:16528409
RGD:401960098
NCBI chrNW_004624790:5,850,647...5,885,754
Ensembl chrNW_004624790:5,850,810...5,886,014
G
Ptk2b
protein tyrosine kinase 2 beta
ISO
associated with Obesity
RGD
PMID:16039993
RGD:1642605
NCBI chrNW_004624758:22,065,448...22,182,604
Ensembl chrNW_004624758:22,124,836...22,182,605
G
Ptpn1
protein tyrosine phosphatase non-receptor type 1
ISO
ClinVar Annotator: match by term: Insulin resistance, susceptibility to
ClinVar
PMID:11833006
NCBI chrNW_004624790:5,070,537...5,135,243
Ensembl chrNW_004624790:5,073,476...5,135,181
G
Ptprf
protein tyrosine phosphatase receptor type F
ISO
protein:increased activity, increased expression:skeletal muscle:activity increased to 140-170% of control in insulin-resistant obese (BMI>30) nondiabetic subjects (p<0.05); activity decreased to 39% in obese NIDDM subjects (p<0.05) protein:increased expression::mouse model overexpressing human transgene, fasting plasma insulin increased 2.5-fold, glucose disposal and uptake into muscle reduced
RGD
PMID:9218523 PMID:11309481
RGD:1642733 RGD:1642735
NCBI chrNW_004624892:2,825,771...2,932,854
G
Pyy
peptide YY
ISO
protein:decreased expression
RGD
PMID:17045646
RGD:1625281
NCBI chrNW_004624795:887,963...903,315
Ensembl chrNW_004624795:902,260...903,409
G
Rb1
RB transcriptional corepressor 1
ISO
mRNA:decreased expression:adipose tissue
RGD
PMID:23315497
RGD:8547988
NCBI chrNW_004624748:6,358,588...6,533,217
Ensembl chrNW_004624748:6,358,180...6,533,249
G
Rbp4
retinol binding protein 4
disease_progression ameliorates
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:21365528 PMID:29747616
RGD:329849113 RGD:329853304
NCBI chrNW_004624737:4,795,054...4,800,830
Ensembl chrNW_004624737:4,791,628...4,800,989
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:altered localization:soleus
RGD
PMID:18073321 PMID:18198644
RGD:2298857 RGD:2298860
NCBI chrNW_004624767:20,732,813...20,742,016
Ensembl chrNW_004624767:20,732,938...20,741,272
G
Retn
resistin
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16493877 PMID:18789551
RGD:2313499
NCBI chrNW_004624828:735,562...737,166
Ensembl chrNW_004624828:735,503...737,166
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
ISO
RGD
PMID:16537411
RGD:2311703
NCBI chrNW_004624746:19,584,061...19,587,476
Ensembl chrNW_004624746:19,583,541...19,587,598
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14714311
NCBI chrNW_004624759:12,207,251...12,218,857
G
Serpine1
serpin family E member 1
treatment
ISO
mRNA:increased expression:white adipose tissue (rat)
RGD
PMID:19776253 PMID:26188590
RGD:11073726 RGD:8547949
NCBI chrNW_004624740:16,128,145...16,136,696
Ensembl chrNW_004624740:16,128,059...16,137,337
G
Serpinf1
serpin family F member 1
treatment
ISO
associated with Hypertension human protein in a rat model
RGD
PMID:19073347 PMID:22714715 PMID:24288442
RGD:2312339 RGD:8642993 RGD:8655563
NCBI chrNW_004624786:4,487,005...4,497,706
Ensembl chrNW_004624786:4,486,978...4,497,585
G
Shc1
SHC adaptor protein 1
ISO
mRNA:increased expression:adipose tissue
RGD
PMID:17986714
RGD:1643171
NCBI chrNW_004624885:2,511,039...2,520,883
Ensembl chrNW_004624885:2,511,240...2,521,155
G
Si
sucrase-isomaltase
ISO
associated with Diabetes Mellitus, Type 2;mRNA:increased expression:small intestine
RGD
PMID:9878708
RGD:1625544
NCBI chrNW_004624730:42,984,277...43,112,819
Ensembl chrNW_004624730:42,984,431...43,112,819
G
Sirt1
sirtuin 1
treatment
ISO
associated with Obesity CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:19996381 PMID:20068143 PMID:21321189 PMID:24442997 PMID:25849131 PMID:26026874 More...
RGD:9585759
NCBI chrNW_004624754:2,304,476...2,332,705
Ensembl chrNW_004624754:2,304,634...2,330,946
G
Sirt4
sirtuin 4
ISO
RGD
PMID:20651844
RGD:9586052
NCBI chrNW_004624747:13,329,662...13,352,151
Ensembl chrNW_004624747:13,335,442...13,352,201
G
Slc27a1
solute carrier family 27 member 1
ISO
protein::heart:basal level increased but unresponsive to insulin on a high cholesterol, high fructose diet
RGD
PMID:17400720
RGD:1642795
NCBI chrNW_004624908:531,313...549,570
Ensembl chrNW_004624908:531,308...549,990
G
Slc27a4
solute carrier family 27 member 4
ISO
mRNA:increased expression:subcutaneous adipose tissue
RGD
PMID:15168018
RGD:1625638
NCBI chrNW_004624760:6,529,028...6,542,067
Ensembl chrNW_004624760:6,529,027...6,542,149
G
Slc2a3
solute carrier family 2 member 3
ISO
mRNA,protein:decreased expression:muscle
RGD
PMID:11436180
RGD:1642802
NCBI chrNW_004624860:5,069,246...5,153,435
G
Slc2a4
solute carrier family 2 member 4
ISO
associated with Heart Failure, Congestive;protein:decreased expression:skeletal muscle CTD Direct Evidence: therapeutic
RGD CTD
PMID:11947963 PMID:18778861
RGD:2313624
NCBI chrNW_004624786:9,903,176...9,908,953
Ensembl chrNW_004624786:9,902,509...9,909,684
G
Socs1
suppressor of cytokine signaling 1
ISO
associated with Diabetes Mellitus
RGD
PMID:15240880
RGD:1625677
NCBI chrNW_004624824:8,444,877...8,446,628
G
Socs3
suppressor of cytokine signaling 3
susceptibility
ISO
associated with Obesity associated with Diabetes Mellitus
RGD
PMID:15240880 PMID:17295835
RGD:1625677 RGD:2313789
NCBI chrNW_004624801:7,841,230...7,843,912
Ensembl chrNW_004624801:7,840,889...7,843,860
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22829583
NCBI chrNW_004624855:3,260,800...3,271,864
Ensembl chrNW_004624855:3,260,809...3,271,367
G
Sod3
superoxide dismutase 3
ISO
associated with Diabetes Mellitus, Type 2;protein:increased expression:plasma
RGD
PMID:15171689
RGD:1625698
NCBI chrNW_004624755:7,535,044...7,541,298
Ensembl chrNW_004624755:7,535,044...7,541,221
G
Sorbs1
sorbin and SH3 domain containing 1
susceptibility
ISO
RGD
PMID:17351624
RGD:1642731
NCBI chrNW_004624737:6,646,837...6,875,408
Ensembl chrNW_004624737:6,647,651...6,786,335
G
Sox6
SRY-box transcription factor 6
ISO
RGD
PMID:16148004
RGD:1581307
NCBI chrNW_004624766:7,683,492...8,301,823
Ensembl chrNW_004624766:7,689,775...8,084,764
G
Sqstm1
sequestosome 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33933676
NCBI chrNW_004624733:42,689,454...42,700,916
Ensembl chrNW_004624733:42,691,841...42,700,916
G
Srebf1
sterol regulatory element binding transcription factor 1
treatment susceptibility
ISO
associated with Fatty Liver;mRNA:increased expression:liver associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17241878 PMID:18692268 PMID:22658938 PMID:26394137
RGD:2308807 RGD:2308809 RGD:329955565
NCBI chrNW_004624849:3,602,103...3,623,922
Ensembl chrNW_004624849:3,602,261...3,623,465
G
Srebf2
sterol regulatory element binding transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20699619
NCBI chrNW_004624752:6,815,075...6,871,674
Ensembl chrNW_004624752:6,816,468...6,871,567
G
Stk11
serine/threonine kinase 11
ISO
associated with obesity;protein:decreased expression:gastrocnemius
RGD
PMID:16352671
RGD:1601389
NCBI chrNW_004624828:7,444,339...7,466,926
Ensembl chrNW_004624828:7,445,069...7,467,298
G
Sts
steroid sulfatase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24497646
NCBI chrNW_004624834:4,805,556...4,975,264
Ensembl chrNW_004624834:4,853,045...4,978,111
G
Syn1
synapsin I
ISO
RGD
PMID:29566703
RGD:13542091
NCBI chrNW_004624978:110,640...179,910
Ensembl chrNW_004624978:110,506...180,568
G
Tbc1d4
TBC1 domain family member 4
ISO
ClinVar Annotator: match by term: Insulin resistance
ClinVar
NCBI chrNW_004624751:24,999,301...25,183,905
Ensembl chrNW_004624751:24,999,386...25,181,702
G
Tcf7l2
transcription factor 7 like 2
ISO
DNA:SNP (human)
RGD
PMID:19509102
RGD:2312433
NCBI chrNW_004624737:33,341,574...33,526,814
Ensembl chrNW_004624737:33,341,029...33,526,928
G
Tfap2b
transcription factor AP-2 beta
ISO
RGD
PMID:16373417
RGD:1601544
NCBI chrNW_004624855:5,353,347...5,381,454
Ensembl chrNW_004624855:5,355,239...5,381,477
G
Thbd
thrombomodulin
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent
RGD
PMID:11453033
RGD:2312460
NCBI chrNW_004624741:22,880,481...22,883,962
G
Tlr4
toll like receptor 4
severity
ISO
associated with Obesity protein:increased expression:skeletal muscle
RGD
PMID:17426960 PMID:18633101 PMID:19675137
RGD:1620681 RGD:2312483 RGD:2312489
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
G
Tnf
tumor necrosis factor
treatment
ISO
associated with Obesity CTD Direct Evidence: marker/mechanism associated with obesity
RGD CTD
PMID:9832430 PMID:14764603 PMID:16202847 PMID:16493877 PMID:20943792 PMID:25016878 More...
RGD:10450578 RGD:14995428 RGD:1580214 RGD:1580312
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
G
Tnfrsf11b
TNF receptor superfamily member 11b
ISO
associated with obesity;protein:increased expression:serum
RGD
PMID:15936463
RGD:1620889
NCBI chrNW_004624763:17,139,109...17,166,398
Ensembl chrNW_004624763:17,138,847...17,166,453
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:decreased expression
RGD
PMID:11882518
RGD:1624180
NCBI chrNW_004624860:3,111,244...3,123,041
Ensembl chrNW_004624860:3,111,630...3,122,711
G
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20461355
NCBI chrNW_004624741:1,486,223...1,494,005
Ensembl chrNW_004624741:1,484,863...1,494,829
G
Tsc1
TSC complex subunit 1
ISO
RGD
PMID:15380067
RGD:1624197
NCBI chrNW_004624760:3,479,028...3,536,612
Ensembl chrNW_004624760:3,498,692...3,532,011
G
Ucp1
uncoupling protein 1
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP:5' utr:-112A>C (rs10011540) (human)
RGD
PMID:16338218
RGD:1624979
NCBI chrNW_004625006:155,179...162,544
Ensembl chrNW_004625006:155,100...162,551
G
Ucp2
uncoupling protein 2
ISO
DNA:polymorphism, insertion:promoter:-866G>A (rs659366)(human)
RGD
PMID:17870627
RGD:2313512
NCBI chrNW_004624817:3,067,358...3,075,045
Ensembl chrNW_004624817:3,067,320...3,075,043
G
Vcam1
vascular cell adhesion molecule 1
ISO
RGD
PMID:11882338
RGD:1580351
NCBI chrNW_004624857:3,606,573...3,625,991
Ensembl chrNW_004624857:3,606,431...3,627,063
G
Vdr
vitamin D receptor
ISO
RGD
PMID:25801026
RGD:14402022
NCBI chrNW_004624816:4,314,146...4,423,946
Ensembl chrNW_004624816:4,365,961...4,424,514
G
Vwf
von Willebrand factor
ISO
protein:increased expression:plasma
RGD
PMID:16631442
RGD:1625711
NCBI chrNW_004624860:2,843,268...2,973,888
Ensembl chrNW_004624860:2,858,088...2,973,052
G
Xbp1
X-box binding protein 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:15486293 PMID:26394137 PMID:27325692
RGD:2326004 RGD:329955565
NCBI chrNW_004624747:5,123,085...5,128,465
G
Zc3h10
zinc finger CCCH-type containing 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:31775033
NCBI chrNW_004624802:11,886,029...11,891,640
Ensembl chrNW_004624802:11,886,878...11,891,491
G
Ctf1
cardiotrophin 1
ISO
MouseDO
NCBI chrNW_004624782:13,976,308...13,979,327
G
Gucy2c
guanylate cyclase 2C
ISO
MouseDO
NCBI chrNW_004624752:23,285,987...23,357,662
Ensembl chrNW_004624752:23,286,093...23,357,662
G
Lep
leptin
ISO
MouseDO
NCBI chrNW_004624783:7,708,820...7,721,610
Ensembl chrNW_004624783:7,708,588...7,721,727
G
Neil1
nei like DNA glycosylase 1
ISO
MouseDO
NCBI chrNW_004624894:282,799...287,265
Ensembl chrNW_004624894:282,695...288,058
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15309680
NCBI chrNW_004624752:3,646,499...3,702,553
Ensembl chrNW_004624752:3,650,922...3,701,672
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
MouseDO
NCBI chrNW_004624956:84,673...207,176
Ensembl chrNW_004624956:83,842...149,481
G
Ppargc1a
PPARG coactivator 1 alpha
ISO
mRNA:increased expression:gastrocnemius muscle (rat)
RGD
PMID:23320128
RGD:7241841
NCBI chrNW_004624755:7,826,219...8,460,746
Ensembl chrNW_004624755:8,375,596...8,465,297
G
Prkci
protein kinase C iota
ISO
MouseDO
NCBI chrNW_004624730:48,258,524...48,340,217
G
Sirt3
sirtuin 3
ISO
MouseDO
NCBI chrNW_004624766:22,199,741...22,233,933
Ensembl chrNW_004624766:22,199,601...22,233,933
G
Slc2a9
solute carrier family 2 member 9
ISO
MouseDO
NCBI chrNW_004624755:21,165,374...21,328,843
Ensembl chrNW_004624755:21,171,274...21,322,543
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
ISO
protein:increased oxidation:cardiac muscle cell
RGD
PMID:23997093
RGD:13782087
NCBI chrNW_004624747:21,509,360...21,567,424
Ensembl chrNW_004624747:21,509,366...21,568,098
G
Bax
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:27131981
RGD:13792503
NCBI chrNW_004624832:5,050,222...5,068,565
Ensembl chrNW_004624832:5,050,222...5,055,506
G
Bcl2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:27131981
RGD:13792503
NCBI chrNW_004624792:8,854,345...9,032,727
Ensembl chrNW_004624792:8,859,522...9,031,344
G
Fadd
Fas associated via death domain
treatment
ISO
RGD
PMID:27131981
RGD:13792503
NCBI chrNW_004624767:17,050,929...17,059,648
Ensembl chrNW_004624767:17,055,509...17,059,705
G
Fas
Fas cell surface death receptor
ISO
RGD
PMID:30172001
RGD:13792561
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
G
Lep
leptin
ISO
OMIM:605552
MouseDO
NCBI chrNW_004624783:7,708,820...7,721,610
Ensembl chrNW_004624783:7,708,588...7,721,727
G
Lpl
lipoprotein lipase
treatment
ISO
RGD
PMID:26996629
RGD:13794382
NCBI chrNW_004624758:15,652,553...15,680,107
Ensembl chrNW_004624758:15,651,992...15,680,762
G
Mttp
microsomal triglyceride transfer protein
ISO
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 1
ClinVar
PMID:8533758 PMID:9671739 PMID:16721486 PMID:25741868 PMID:28492532
NCBI chrNW_004624830:7,463,671...7,505,607
Ensembl chrNW_004624830:7,464,686...7,506,129
G
Tlr2
toll like receptor 2
susceptibility
ISO
RGD
PMID:19841034
RGD:15090861
NCBI chrNW_004624858:4,931,820...4,984,175
Ensembl chrNW_004624858:4,979,485...4,981,833
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
ISO
OMIM:605552
MouseDO
NCBI chrNW_004624763:2,278,751...2,297,149
Ensembl chrNW_004624763:2,277,794...2,296,423
G
Ahdc1
AT-hook DNA binding motif containing 1
ISO
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 3
ClinVar
PMID:25741868 PMID:29696776 PMID:33644933
NCBI chrNW_004624764:11,416,674...11,482,622
Ensembl chrNW_004624764:11,416,674...11,482,601
G
Dyrk1b
dual specificity tyrosine phosphorylation regulated kinase 1B
ISO
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 3 | ClinVar Annotator: match by term: CENTRAL OBESITY, TYPE 2 DIABETES, HYPERTENSION, AND EARLY-ONSET CORONARY ARTERY DISEASE | ClinVar Annotator: match by term: DYRK1B-related condition
OMIM ClinVar
PMID:9536098 PMID:17576681 PMID:24827035 PMID:25741868 PMID:28492532 PMID:32041611 More...
NCBI chrNW_004624925:40,175...56,177
Ensembl chrNW_004624925:46,748...55,481
G
Insr
insulin receptor
ISO
ClinVar Annotator: match by term: DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS, TYPE A | ClinVar Annotator: match by term: IRAN, TYPE A
OMIM ClinVar
PMID:1644241 PMID:1963473 PMID:1971035 PMID:2002058 PMID:2040394 PMID:2121734 PMID:2203761 PMID:2211730 PMID:2365819 PMID:2460770 PMID:2544997 PMID:2544998 PMID:2662406 PMID:2859121 PMID:2983222 PMID:3283938 PMID:3384956 PMID:3510919 PMID:6339538 PMID:7042734 PMID:7657032 PMID:8096518 PMID:8257688 PMID:8288049 PMID:8314008 PMID:8432414 PMID:8900242 PMID:10084586 PMID:10933564 PMID:11463381 PMID:13302174 PMID:15161766 PMID:19135752 PMID:22775283 PMID:23705494 PMID:24033266 PMID:25741868 PMID:26874853 PMID:27840822 PMID:27896077 PMID:28492532 PMID:28765322 PMID:30663027 PMID:31989990 PMID:35000900 More...
NCBI chrNW_004624828:345,135...485,856
Ensembl chrNW_004624828:345,135...486,184
G
Lmna
lamin A/C
ISO
ClinVar Annotator: match by term: IRAN, TYPE A
ClinVar
PMID:15919811 PMID:16478798 PMID:20848652 PMID:23785128 PMID:24033266 PMID:25637381 PMID:25741868 PMID:28492532 PMID:28663758 PMID:33661429 More...
NCBI chrNW_004624885:1,423,563...1,466,657
Ensembl chrNW_004624885:1,447,395...1,467,554
G
Abca1
ATP binding cassette subfamily A member 1
susceptibility
ISO
DNA:SNP:exon:p.R230C (rs9282541) (human)
RGD
PMID:17287470
RGD:1601092
NCBI chrNW_004624758:6,449,583...6,590,244
Ensembl chrNW_004624758:6,449,629...6,588,664
G
Acaca
acetyl-CoA carboxylase alpha
ameliorates
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:27821167 PMID:29684438
RGD:329333017 RGD:401799622
NCBI chrNW_004624871:4,103,014...4,364,690
Ensembl chrNW_004624871:4,105,067...4,412,325
G
Acacb
acetyl-CoA carboxylase beta
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:29684438
RGD:329333017
NCBI chrNW_004624747:12,287,817...12,426,340
Ensembl chrNW_004624747:12,307,541...12,424,897
G
Acadvl
acyl-CoA dehydrogenase very long chain
treatment
ISO
RGD
PMID:25191539
RGD:10047118
NCBI chrNW_004624786:9,838,102...9,843,506
Ensembl chrNW_004624786:9,838,227...9,843,332
G
Acat2
acetyl-CoA acetyltransferase 2
susceptibility
ISO
DNA:polymorphism
RGD
PMID:14557872
RGD:1581921
NCBI chrNW_004624855:3,177,402...3,199,634
Ensembl chrNW_004624855:3,176,171...3,199,705
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP: :276G>T (human) CTD Direct Evidence: marker/mechanism protein:decreased expression:serum associated with vascular diseases; protein:decreased expression:plasma
RGD CTD
PMID:16793964 PMID:17618945 PMID:17893004 PMID:18162013 PMID:19690575 PMID:20833989 PMID:21625822 PMID:21976521 More...
RGD:2313234 RGD:5686407 RGD:5686428 RGD:5686800
NCBI chrNW_004624730:69,941,963...69,959,266
Ensembl chrNW_004624730:69,941,001...69,957,012
G
Adrb2
adrenoceptor beta 2
susceptibility
ISO
DNA:polymorphisms: :p.R16G, p.Q27E
RGD
PMID:14557466
RGD:1601127
NCBI chrNW_004624774:8,211,723...8,215,962
Ensembl chrNW_004624774:8,211,984...8,213,240
G
Agt
angiotensinogen
ISO
mRNA, protein:increased expression:adipose tissue
RGD
PMID:17260464
RGD:1601134
NCBI chrNW_004624775:18,846,222...18,856,093
Ensembl chrNW_004624775:18,849,118...18,855,577
G
Agtr1
angiotensin II receptor type 1
susceptibility
ISO
DNA:snp:3' utr:c.5186A>C
RGD
PMID:17211857
RGD:1601146
NCBI chrNW_004624730:25,964,848...26,006,468
Ensembl chrNW_004624730:25,964,811...26,006,463
G
Alpl
alkaline phosphatase, biomineralization associated
susceptibility
ISO
protein:increased expression:serum
RGD
PMID:16249437
RGD:1601174
NCBI chrNW_004624764:6,393,741...6,447,739
Ensembl chrNW_004624764:6,393,765...6,447,829
G
Apoa1
apolipoprotein A1
ISO
protein:decreased expression:serum (human) DNA: polymorphism: :G2, G3 and G5
RGD
PMID:17217166 PMID:21410987
RGD:1601183 RGD:5508220
NCBI chrNW_004624784:12,249,283...12,251,215
Ensembl chrNW_004624784:12,249,283...12,251,136
G
Apoa2
apolipoprotein A2
ISO
protein:decreased expression:serum
RGD
PMID:19817643
RGD:2313955
NCBI chrNW_004624794:164,351...165,676
Ensembl chrNW_004624794:164,370...166,248
G
Apoa5
apolipoprotein A5
susceptibility
ISO
DNA:polymorphism: :p.S19W (human)
RGD
PMID:18789138
RGD:2313315
NCBI chrNW_004624784:12,213,205...12,216,039
Ensembl chrNW_004624784:12,213,744...12,216,026
G
Apob
apolipoprotein B
ISO
protein:increased expression:plasma
RGD
PMID:16828905
RGD:1601198
NCBI chrNW_004624738:3,579,747...3,622,508
Ensembl chrNW_004624738:3,580,033...3,620,192
G
Apoc3
apolipoprotein C3
susceptibility
ISO
protein:increased expression:serum (human) DNA:polymorphism:promoter:-482C>T, -455T>C
RGD
PMID:16298371 PMID:17416293
RGD:1601223 RGD:2306766
NCBI chrNW_004624784:12,244,565...12,246,790
Ensembl chrNW_004624784:12,244,646...12,246,790
G
Apom
apolipoprotein M
ISO
protein:decreased expression:plasma
RGD
PMID:19539616
RGD:2314236
NCBI chrNW_004624754:24,554,705...24,558,093
Ensembl chrNW_004624754:24,554,705...24,557,098
G
Atm
ATM serine/threonine kinase
ISO
RGD
PMID:17084711
RGD:1601248
NCBI chrNW_004624784:2,933,172...3,080,131
Ensembl chrNW_004624784:2,937,499...3,078,216
G
Atp12a
ATPase H+/K+ transporting non-gastric alpha2 subunit
ISO
RGD
PMID:23320804
RGD:13838660
NCBI chrNW_004624776:18,466,952...18,495,693
Ensembl chrNW_004624776:18,467,967...18,495,651
G
Bche
butyrylcholinesterase
ISO
protein:increased expression:serum
RGD
PMID:15907830
RGD:1601317
NCBI chrNW_004624730:43,793,550...43,849,169
Ensembl chrNW_004624730:43,793,040...43,843,519
G
Bdnf
brain derived neurotrophic factor
ISO
RGD
PMID:11935372
RGD:1580935
NCBI chrNW_004624766:17,281,882...17,330,601
Ensembl chrNW_004624766:17,279,630...17,330,490
G
Bglap
bone gamma-carboxyglutamate protein
ISO
protein:decreased expression:serum
RGD
PMID:21760737
RGD:6483594
NCBI chrNW_004624885:1,526,625...1,528,235
Ensembl chrNW_004624885:1,527,538...1,528,109
G
C3
complement C3
ISO
RGD
PMID:16488421
RGD:2314030
NCBI chrNW_004624828:3,773,816...3,798,077
Ensembl chrNW_004624828:3,770,221...3,797,946
G
Capn10
calpain 10
ISO
DNA:polymorphism
RGD
PMID:16546286
RGD:1625050
NCBI chrNW_004624847:4,911,052...4,922,549
Ensembl chrNW_004624847:4,911,737...4,922,192
G
Cck
cholecystokinin
ISO
protein:decreased expression:plasma:associated with Obesity, Morbid (MeSH:D009767)
RGD
PMID:17443025
RGD:1625798
NCBI chrNW_004624730:77,310,080...77,314,258
Ensembl chrNW_004624730:77,309,633...77,314,384
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:plasma (rat)
RGD
PMID:19905967
RGD:4889977
NCBI chrNW_004624875:3,334,136...3,342,085
Ensembl chrNW_004624875:3,334,078...3,341,614
G
Cd163
CD163 molecule
susceptibility
ISO
protein:increased expression:blood serum (human)
RGD
PMID:31027316
RGD:127345132
NCBI chrNW_004624860:3,976,746...4,000,349
Ensembl chrNW_004624860:3,975,747...4,000,349
G
Cd36
CD36 molecule (CD36 blood group)
ISO
DNA:SNPs: :multiple (human)
RGD
PMID:9916795 PMID:18305138
RGD:2307208 RGD:619666
NCBI chrNW_004624739:29,341,620...29,441,232
Ensembl chrNW_004624739:29,407,568...29,441,333
G
Cd40lg
CD40 ligand
ISO
protein:increased expression:serum
RGD
PMID:16423632 PMID:20006362
RGD:2314214 RGD:5490591
NCBI chrNW_004624808:10,472,028...10,484,407
Ensembl chrNW_004624808:10,472,572...10,484,338
G
Chek2
checkpoint kinase 2
ISO
mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:25129990
RGD:10400905
NCBI chrNW_004624747:5,035,045...5,072,555
Ensembl chrNW_004624747:5,035,200...5,070,332
G
Ciita
class II major histocompatibility complex transactivator
ISO
DNA:polymorphism:promoter:-168A>G
RGD
PMID:17183695
RGD:5491201
NCBI chrNW_004624824:8,099,877...8,156,661
Ensembl chrNW_004624824:8,116,537...8,153,482
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16644639 PMID:21357282
RGD:6482318
NCBI chrNW_004624794:1,531,555...1,533,804
Ensembl chrNW_004624794:1,531,571...1,533,804
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
RGD
PMID:32360427
RGD:151347874
NCBI chrNW_004624754:24,881,439...24,905,633
Ensembl chrNW_004624754:24,880,496...24,896,995
G
Dgat1
diacylglycerol O-acyltransferase 1
treatment
ISO
RGD
PMID:21990351
RGD:10401057
NCBI chrNW_004624735:12,525,120...12,535,436
Ensembl chrNW_004624735:12,525,284...12,535,193
G
Dio2
iodothyronine deiodinase 2
ISO
DNA:polymorphism: :p.T92A (human)
RGD
PMID:18198294
RGD:2313696
NCBI chrNW_004624734:21,787,705...21,802,096
G
Ephx2
epoxide hydrolase 2
ISO
RGD
PMID:22007192
RGD:5688391
NCBI chrNW_004624758:22,216,462...22,252,467
Ensembl chrNW_004624758:22,221,314...22,254,813
G
F3
coagulation factor III, tissue factor
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent
RGD
PMID:12417540
RGD:2313865
NCBI chrNW_004624742:3,112,827...3,123,424
Ensembl chrNW_004624742:3,112,801...3,124,301
G
Fadd
Fas associated via death domain
ISO
protein:increased expression:heart left ventricle
RGD
PMID:23657904
RGD:11344884
NCBI chrNW_004624767:17,050,929...17,059,648
Ensembl chrNW_004624767:17,055,509...17,059,705
G
Fas
Fas cell surface death receptor
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:11934685
RGD:628329
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
G
Fasn
fatty acid synthase
ameliorates
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:27821167 PMID:29684438 PMID:31353547
RGD:329333017 RGD:401799622 RGD:401850595
NCBI chrNW_004624801:10,910,022...10,926,505
Ensembl chrNW_004624801:10,909,647...10,927,547
G
Fgf19
fibroblast growth factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28673684
NCBI chrNW_004624767:17,434,501...17,439,351
Ensembl chrNW_004624767:17,432,358...17,438,173
G
Fgf21
fibroblast growth factor 21
treatment
ISO
RGD
PMID:25306889
RGD:10401890
NCBI chrNW_004624832:5,165,195...5,166,865
Ensembl chrNW_004624832:5,164,856...5,167,370
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
ISO
DNA:SNPs: :rs1421085, rs1558902, rs8050136, rs9939609 (human) DNA:SNP: :rs9939973 (human)
RGD
PMID:21796137 PMID:32061761
RGD:329853776 RGD:329901771
NCBI chrNW_004624757:2,675,810...3,081,751
Ensembl chrNW_004624757:2,675,671...3,080,480
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
ameliorates
ISO
RGD
PMID:27821167
RGD:401799622
NCBI chrNW_004624795:1,331,592...1,339,575
Ensembl chrNW_004624795:1,331,601...1,339,580
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:19374165 PMID:24868532
RGD:10449117 RGD:2307350
NCBI chrNW_004624946:989,376...1,001,787
Ensembl chrNW_004624946:986,107...1,001,955
G
Gcg
glucagon
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624732:3,361,897...3,370,020
Ensembl chrNW_004624732:3,362,234...3,370,536
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:34200262
RGD:329970293
NCBI chrNW_004624731:14,459,164...14,502,485
Ensembl chrNW_004624731:14,459,303...14,500,429
G
Gck
glucokinase
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624740:7,844,496...7,885,900
Ensembl chrNW_004624740:7,852,390...7,886,758
G
Gckr
glucokinase regulator
ISO
RGD
PMID:19861489
RGD:7242423
NCBI chrNW_004624738:9,552,260...9,574,082
Ensembl chrNW_004624738:9,552,386...9,574,082
G
Ggt1
gamma-glutamyltransferase 1
susceptibility
ISO
RGD
PMID:17095717 PMID:24847614
RGD:14747015 RGD:1601300
NCBI chrNW_004624747:10,030,034...10,048,554
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
ClinVar Annotator: match by term: Metabolic syndrome, susceptibility to
ClinVar
PMID:11502844 PMID:12050239 PMID:12161552 PMID:16204371 PMID:25741868
NCBI chrNW_004624731:5,257,813...5,262,878
Ensembl chrNW_004624731:5,257,830...5,262,473
G
Gpr17
G protein-coupled receptor 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34144038
NCBI chrNW_004624732:14,115,267...14,129,714
Ensembl chrNW_004624732:14,115,325...14,128,169
G
Gpx3
glutathione peroxidase 3
ISO
protein:increased expression:serum
RGD
PMID:24819036
RGD:401827122
NCBI chrNW_004624733:40,957,895...40,963,469
Ensembl chrNW_004624733:40,957,999...40,962,993
G
Gsn
gelsolin
severity
ISO
RGD
PMID:29684438
RGD:329333017
NCBI chrNW_004624760:13,943,680...14,004,660
Ensembl chrNW_004624760:13,943,888...13,969,905
G
Hdac3
histone deacetylase 3
ISO
RGD
PMID:21763752
RGD:9590183
NCBI chrNW_004624774:845,970...864,080
Ensembl chrNW_004624774:845,358...863,809
G
Hgf
hepatocyte growth factor
ISO
study in the Japanese population
RGD
PMID:15713721
RGD:1642702
NCBI chrNW_004624739:30,233,589...30,307,508
Ensembl chrNW_004624739:30,236,146...30,307,356
G
Hmga1
high mobility group AT-hook 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23512162
NCBI chrNW_004624754:22,888,052...22,900,685
Ensembl chrNW_004624754:22,892,226...22,898,807
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
ameliorates
ISO
RGD
PMID:19461650 PMID:27821167 PMID:31353547
RGD:401799622 RGD:401850595 RGD:5508692
NCBI chrNW_004624951:681,559...711,476
Ensembl chrNW_004624951:682,178...711,474
G
Hmox1
heme oxygenase 1
treatment
ISO
RGD
PMID:22193921
RGD:10763276
NCBI chrNW_004624750:341,699...346,005
Ensembl chrNW_004624750:342,146...345,887
G
Hnf4a
hepatocyte nuclear factor 4 alpha
ISO
Finnish population; DNA:haplotype:CDS:SNPs rs6031558-rs745975-rs3212198, haplotype H1A (1-1-2)
RGD
PMID:16804065
RGD:1601642
NCBI chrNW_004624790:10,039,344...10,065,167
Ensembl chrNW_004624790:10,038,999...10,100,649
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
susceptibility disease_progression
ISO
DNA:SNPs:5'utr,enhancer: (rs846910,rs12086634) (human) DNA:SNP:: (rs846910) (human) DNA:SNP: (rs12086634)T>G (human) mRNA:increased expression:ascending aorta,epicardial fat (human)
RGD
PMID:14697232 PMID:21622477 PMID:23007990 PMID:23869418 PMID:28750217
RGD:1625074 RGD:329901909 RGD:329901919 RGD:329901929 RGD:329901930
NCBI chrNW_004624807:2,260,702...2,293,962
Ensembl chrNW_004624807:2,261,006...2,293,804
G
Htr2c
5-hydroxytryptamine receptor 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17632216 PMID:18515891 PMID:19142101
NCBI chrNW_004624940:1,040,744...1,299,266
Ensembl chrNW_004624940:1,040,911...1,157,057
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:serum
RGD
PMID:19394054
RGD:2313467
NCBI chrNW_004624828:2,432,584...2,451,997
Ensembl chrNW_004624828:2,432,550...2,453,071
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
susceptibility
ISO
RGD
PMID:31064654
RGD:14985252
NCBI chrNW_004624768:17,094,649...17,111,333
Ensembl chrNW_004624768:17,094,655...17,111,397
G
Igf2
insulin like growth factor 2
ISO
DNA:insertion
RGD
PMID:18418699
RGD:2311520
NCBI chrNW_004624767:14,969,977...14,997,577
Ensembl chrNW_004624767:14,969,866...14,979,026
G
Igfbp2
insulin like growth factor binding protein 2
ISO
RGD
PMID:16915540
RGD:1626481
NCBI chrNW_004624823:8,460,968...8,486,495
Ensembl chrNW_004624823:8,460,553...8,486,495
G
Il18
interleukin 18
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
RGD CTD
PMID:16644639 PMID:19717152 PMID:24456735
RGD:4889401 RGD:8655985
NCBI chrNW_004624784:7,294,286...7,312,959
Ensembl chrNW_004624784:7,294,183...7,304,687
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16644639
NCBI chrNW_004624739:7,957,709...7,963,414
Ensembl chrNW_004624739:7,957,674...7,962,318
G
Il6r
interleukin 6 receptor
susceptibility
ISO
DNA:polymorphism: :p.D358A
RGD
PMID:16817825
RGD:1625430
NCBI chrNW_004624885:2,910,367...2,946,916
Ensembl chrNW_004624885:2,910,112...2,946,886
G
Inppl1
inositol polyphosphate phosphatase like 1
ISO
DNA:SNPs: :rs2276047,snp8(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15220217
RGD:1626127
NCBI chrNW_004624817:4,779,875...4,794,644
Ensembl chrNW_004624817:4,779,057...4,793,732
G
Ins
insulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11274935 PMID:16259526
NCBI chrNW_004624767:14,999,088...15,000,035
Ensembl chrNW_004624767:14,999,088...15,000,035
G
Insr
insulin receptor
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624828:345,135...485,856
Ensembl chrNW_004624828:345,135...486,184
G
Irs1
insulin receptor substrate 1
ameliorates
ISO
protein:decreased expression:skeletal muscle
RGD
PMID:10842668 PMID:31353547
RGD:401850595 RGD:6482864
NCBI chrNW_004624843:1,113,075...1,178,859
Ensembl chrNW_004624843:1,120,974...1,178,859
G
Irs2
insulin receptor substrate 2
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624793:2,615,092...2,636,835
Ensembl chrNW_004624793:2,614,589...2,636,947
G
Itgav
integrin subunit alpha V
ISO
RGD
PMID:16784924
RGD:1627640
NCBI chrNW_004624899:3,235,434...3,292,584
Ensembl chrNW_004624899:3,239,112...3,291,586
G
Kl
klotho
ISO
mRNA:decreased expression:kidney:
RGD
PMID:11027545
RGD:10403056
NCBI chrNW_004624915:95,155...110,834
G
Lbp
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23349936
NCBI chrNW_004624842:1,306,299...1,332,269
Ensembl chrNW_004624842:1,301,831...1,332,346
G
Ldlr
low density lipoprotein receptor
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624828:2,999,122...3,021,893
Ensembl chrNW_004624828:2,999,169...3,021,987
G
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma (rat)
CTD RGD
PMID:16793964 PMID:18515891 PMID:19462476 PMID:25380250
RGD:10053625 RGD:2311125
NCBI chrNW_004624783:7,708,820...7,721,610
Ensembl chrNW_004624783:7,708,588...7,721,727
G
Lepr
leptin receptor
ISO
DNA:mutations::cds: : (rat) DNA:mutations:cds: : (rat)
RGD
PMID:10901178 PMID:28746409 PMID:32710530
RGD:401960103 RGD:401965413 RGD:401965414
NCBI chrNW_004624742:29,221,742...29,313,273
Ensembl chrNW_004624742:29,223,392...29,337,049
G
Lipe
lipase E, hormone sensitive type
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:29684438
RGD:329333017
NCBI chrNW_004624907:360,462...379,266
Ensembl chrNW_004624907:363,572...379,194
G
Lipg
lipase G, endothelial type
ISO
RGD
PMID:16354105
RGD:1580865
NCBI chrNW_004624778:13,107,037...13,133,162
Ensembl chrNW_004624778:13,107,283...13,133,270
G
Lmna
lamin A/C
ISO
DNA:SNP: :c.138747C>T (human)
RGD
PMID:15205219
RGD:2306121
NCBI chrNW_004624885:1,423,563...1,466,657
Ensembl chrNW_004624885:1,447,395...1,467,554
G
LOC101700701
cytochrome P450 11B1, mitochondrial
susceptibility
ISO
DNA:polymorphism:promoter:-344C>T (human)
RGD
PMID:17261471
RGD:2307294
NCBI chrNW_004624735:13,701,382...13,708,750
G
LOC101701685
cholesterol 7-alpha-monooxygenase
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624744:33,563,564...33,619,851
Ensembl chrNW_004624744:33,612,901...33,619,869
G
LOC101717043
cytochrome b-245 light chain
ISO
RGD
PMID:16741160
RGD:2317864
NCBI chrNW_004624746:911,852...919,361
Ensembl chrNW_004624746:911,842...919,362
G
LOC101719398
serotransferrin
susceptibility
ISO
protein:increased expression:serum
RGD
PMID:17416791
RGD:1601514
NCBI chrNW_004624730:10,078,165...10,109,349
G
Lrp6
LDL receptor related protein 6
ISO
DNA:missense mutation:cds
RGD
PMID:17332414
RGD:2298725
NCBI chrNW_004624752:25,605,444...25,756,573
Ensembl chrNW_004624752:25,605,302...25,751,893
G
Lrpap1
LDL receptor related protein associated protein 1
susceptibility
ISO
associated with Coronary Disease;DNA:SNP:exon
RGD
PMID:14557872
RGD:1581921
NCBI chrNW_004624755:24,436,128...24,447,923
Ensembl chrNW_004624755:24,436,208...24,449,147
G
Map2k2
mitogen-activated protein kinase kinase 2
ISO
mRNA:decreased expression:blood, leukocyte (human)
RGD
PMID:26956845
RGD:155791561
NCBI chrNW_004624828:5,489,085...5,511,166
Ensembl chrNW_004624828:5,488,814...5,511,445
G
Mlxipl
MLX interacting protein like
ameliorates
ISO
RGD
PMID:27821167
RGD:401799622
NCBI chrNW_004624740:14,150,425...14,187,687
Ensembl chrNW_004624740:14,168,238...14,187,264
G
Mtmr9
myotubularin related protein 9
ISO
DNA:SNP: :rs2293855 (human)
RGD
PMID:21796137
RGD:329853776
NCBI chrNW_004624758:24,993,783...25,033,130
Ensembl chrNW_004624758:24,994,164...25,027,682
G
Mttp
microsomal triglyceride transfer protein
ISO
ClinVar Annotator: match by term: Metabolic syndrome X
ClinVar
PMID:8533758 PMID:9671739 PMID:16721486 PMID:25741868 PMID:28492532
NCBI chrNW_004624830:7,463,671...7,505,607
Ensembl chrNW_004624830:7,464,686...7,506,129
G
Nampt
nicotinamide phosphoribosyltransferase
ISO
protein:increased expression:plasma DNA:repeats:intron
RGD
PMID:15922301 PMID:17556870
RGD:1642337 RGD:1642345
NCBI chrNW_004624739:23,411,478...23,444,590
Ensembl chrNW_004624739:23,411,488...23,442,359
G
Neil1
nei like DNA glycosylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16446448 PMID:17389588
NCBI chrNW_004624894:282,799...287,265
Ensembl chrNW_004624894:282,695...288,058
G
Ngf
nerve growth factor
ISO
RGD
PMID:11935372
RGD:1580935
NCBI chrNW_004624772:11,009,765...11,070,050
Ensembl chrNW_004624772:11,010,845...11,070,017
G
Nnmt
nicotinamide N-methyltransferase
ISO
mRNA,protein:increased expression,increased activity:adipose tissue (rat)
RGD
PMID:25719492
RGD:401793724
NCBI chrNW_004624784:9,765,582...9,783,004
Ensembl chrNW_004624784:9,765,582...9,783,004
G
Nos3
nitric oxide synthase 3
treatment
ISO
ClinVar Annotator: match by term: Metabolic syndrome, susceptibility to
RGD ClinVar
PMID:28361419 PMID:28967023
RGD:13461762
NCBI chrNW_004624800:5,600,215...5,619,020
Ensembl chrNW_004624800:5,600,212...5,619,004
G
Nox1
NADPH oxidase 1
ISO
protein:increased expression, increased activity:peripheral blood mononuclear cell (human)
RGD
PMID:16380495
RGD:1580973
NCBI chrNW_004624902:1,741,921...1,754,932
Ensembl chrNW_004624902:1,736,704...1,755,504
G
Nr1h3
nuclear receptor subfamily 1 group H member 3
ameliorates
ISO
RGD
PMID:27821167
RGD:401799622
NCBI chrNW_004624767:1,459,601...1,473,224
Ensembl chrNW_004624767:1,459,601...1,467,795
G
Nr1i2
nuclear receptor subfamily 1 group I member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20869355
NCBI chrNW_004624731:28,371,707...28,405,327
Ensembl chrNW_004624731:28,371,707...28,381,357
G
Nr1i3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20869355
NCBI chrNW_004624794:141,316...158,059
G
Pck1
phosphoenolpyruvate carboxykinase 1
ameliorates
ISO
RGD
PMID:27821167
RGD:401799622
NCBI chrNW_004624741:23,985,257...23,990,354
Ensembl chrNW_004624741:23,985,675...23,989,790
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624862:4,873,457...4,895,836
Ensembl chrNW_004624862:4,879,561...4,895,776
G
Pde9a
phosphodiesterase 9A
treatment
ISO
RGD
PMID:34618683
RGD:242170038
NCBI chrNW_004624745:27,834,814...27,919,264
Ensembl chrNW_004624745:27,839,682...27,919,299
G
Pla2g4a
phospholipase A2 group IVA
ISO
mRNA:decreased expression:liver
RGD
PMID:21172452
RGD:6482748
NCBI chrNW_004624814:6,597,248...6,744,294
Ensembl chrNW_004624814:6,597,005...6,744,286
G
Pla2g6
phospholipase A2 group VI
ISO
mRNA:decreased expression:liver
RGD
PMID:21172452
RGD:6482748
NCBI chrNW_004624752:9,792,778...9,841,817
Ensembl chrNW_004624752:9,792,807...9,843,457
G
Pla2g7
phospholipase A2 group VII
ISO
mRNA:increased expression:liver
RGD
PMID:21172452
RGD:6482748
NCBI chrNW_004624754:13,905,084...13,932,366
Ensembl chrNW_004624754:13,904,797...13,931,670
G
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:serum
RGD
PMID:18249307
RGD:2311664
NCBI chrNW_004624780:1,014,429...1,063,636
Ensembl chrNW_004624780:1,028,085...1,063,649
G
Pon1
paraoxonase 1
ISO
protein:decreased activity:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:14602783 PMID:21573798
RGD:1642618
NCBI chrNW_004624813:1,953,796...1,979,846
Ensembl chrNW_004624813:1,949,614...1,979,882
G
Ppara
peroxisome proliferator activated receptor alpha
ameliorates
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:11934685 PMID:31353547
RGD:401850595 RGD:628329
NCBI chrNW_004624752:3,646,499...3,702,553
Ensembl chrNW_004624752:3,650,922...3,701,672
G
Pparg
peroxisome proliferator activated receptor gamma
ameliorates no_association
ISO
DNA:SNP: :p.P12A (human)
RGD
PMID:16183630 PMID:16186413 PMID:18959602 PMID:31353547
RGD:1580683 RGD:1580686 RGD:2301843 RGD:401850595
NCBI chrNW_004624956:84,673...207,176
Ensembl chrNW_004624956:83,842...149,481
G
Ppargc1a
PPARG coactivator 1 alpha
ISO
mRNA:decreased expression:gastrocnemius muscle (rat)
RGD
PMID:20383225
RGD:10059661
NCBI chrNW_004624755:7,826,219...8,460,746
Ensembl chrNW_004624755:8,375,596...8,465,297
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624862:3,443,720...3,496,078
Ensembl chrNW_004624862:3,450,078...3,496,142
G
Prl
prolactin
ISO
RGD
PMID:16303834
RGD:1642558
NCBI chrNW_004624756:4,585,542...4,593,285
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:liver
RGD
PMID:17883899
RGD:1642586
NCBI chrNW_004624814:6,897,818...6,904,890
Ensembl chrNW_004624814:6,897,857...6,903,728
G
Rbp4
retinol binding protein 4
disease_progression
ISO
protein:increased expression:blood serum (human) associated with obstructive sleep apnea;protein:increased expression:blood plasma (human)
RGD
PMID:19003725 PMID:19339013
RGD:329845591 RGD:329853307
NCBI chrNW_004624737:4,795,054...4,800,830
Ensembl chrNW_004624737:4,791,628...4,800,989
G
Reg1a
regenerating family member 1 alpha
treatment
ISO
RGD
PMID:21685239
RGD:10044029
NCBI chrNW_004624749:23,993,755...23,995,923
G
Retn
resistin
ISO
DNA:SNP:promoter:-420C>G (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17598818 PMID:18328350
RGD:7207155
NCBI chrNW_004624828:735,562...737,166
Ensembl chrNW_004624828:735,503...737,166
G
Scg3
secretogranin III
ISO
DNA:SNP: :rs3764220 (human)
RGD
PMID:21796137
RGD:329853776
NCBI chrNW_004624731:8,652,648...8,681,905
Ensembl chrNW_004624731:8,650,631...8,681,923
G
Selp
selectin P
ISO
RGD
PMID:19061719
RGD:2312292
NCBI chrNW_004624826:7,510,039...7,544,332
Ensembl chrNW_004624826:7,511,646...7,537,924
G
Serpina12
serpin family A member 12
treatment
ISO
human protein in a mouse model
RGD
PMID:16030142
RGD:1547845
NCBI chrNW_004624734:7,191,049...7,204,386
Ensembl chrNW_004624734:7,191,010...7,206,020
G
Serpine1
serpin family E member 1
treatment
ISO
RGD
PMID:26084260
RGD:11073736
NCBI chrNW_004624740:16,128,145...16,136,696
Ensembl chrNW_004624740:16,128,059...16,137,337
G
Shbg
sex hormone binding globulin
ISO
protein:decreased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16968811 PMID:17884445 PMID:17992261
RGD:2313785
NCBI chrNW_004624786:10,234,484...10,239,034
G
Sim1
SIM bHLH transcription factor 1
ISO
ClinVar Annotator: match by term: SIM1-associated metabolic syndrome
ClinVar
NCBI chrNW_004624810:4,479,589...4,558,735
Ensembl chrNW_004624810:4,479,589...4,558,434
G
Sirt1
sirtuin 1
treatment
ISO
protein:decreased expression:hippocampus (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20068143 PMID:21514307 PMID:25356430
RGD:10053569 RGD:9585758
NCBI chrNW_004624754:2,304,476...2,332,705
Ensembl chrNW_004624754:2,304,634...2,330,946
G
Slc27a1
solute carrier family 27 member 1
susceptibility
ISO
DNA:gene knockout::Slc27a1-/- mice resistant to diet-induced obesity and metabolic syndrome
RGD
PMID:16611988
RGD:1642790
NCBI chrNW_004624908:531,313...549,570
Ensembl chrNW_004624908:531,308...549,990
G
Slc2a1
solute carrier family 2 member 1
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624892:2,110,310...2,148,023
Ensembl chrNW_004624892:2,117,561...2,148,037
G
Slc2a4
solute carrier family 2 member 4
ameliorates
ISO
RGD
PMID:31353547
RGD:401850595
NCBI chrNW_004624786:9,903,176...9,908,953
Ensembl chrNW_004624786:9,902,509...9,909,684
G
Soat2
sterol O-acyltransferase 2
susceptibility
ISO
DNA:SNPs
RGD
PMID:14557872
RGD:1581921
NCBI chrNW_004624904:1,160,275...1,170,249
Ensembl chrNW_004624904:1,160,203...1,170,935
G
Sod2
superoxide dismutase 2
treatment
ISO
RGD
PMID:28875871
RGD:26923956
NCBI chrNW_004624855:3,260,800...3,271,864
Ensembl chrNW_004624855:3,260,809...3,271,367
G
Srebf1
sterol regulatory element binding transcription factor 1
disease_progression ameliorates
ISO
protein:increased expression:liver (mouse) mRNA:increased expression:liver (rat)
RGD
PMID:11934685 PMID:29173234 PMID:31353547
RGD:401827867 RGD:401850595 RGD:628329
NCBI chrNW_004624849:3,602,103...3,623,922
Ensembl chrNW_004624849:3,602,261...3,623,465
G
Tgfb1
transforming growth factor beta 1
ISO
mRNA:increased expression:left heart ventricle
RGD
PMID:18692559
RGD:2306739
NCBI chrNW_004624907:162,567...175,696
Ensembl chrNW_004624907:161,569...176,605
G
Thbd
thrombomodulin
ISO
associated with Diabetic Nephropathies;protein:increased expression:plasma
RGD
PMID:16567841
RGD:1601641
NCBI chrNW_004624741:22,880,481...22,883,962
G
Tlr2
toll like receptor 2
ameliorates
ISO
RGD
PMID:32151955
RGD:597538509
NCBI chrNW_004624858:4,931,820...4,984,175
Ensembl chrNW_004624858:4,979,485...4,981,833
G
Tnf
tumor necrosis factor
treatment
ISO
RGD
PMID:24441717
RGD:10450604
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
associated with obesity;protein:increased expression:plasma
RGD
PMID:17200772
RGD:1624178
NCBI chrNW_004624860:3,111,244...3,123,041
Ensembl chrNW_004624860:3,111,630...3,122,711
G
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18497449
NCBI chrNW_004624741:1,486,223...1,494,005
Ensembl chrNW_004624741:1,484,863...1,494,829
G
Ucp2
uncoupling protein 2
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:11934685
RGD:628329
NCBI chrNW_004624817:3,067,358...3,075,045
Ensembl chrNW_004624817:3,067,320...3,075,043
G
Vcam1
vascular cell adhesion molecule 1
ISO
RGD
PMID:18718174
RGD:2313109
NCBI chrNW_004624857:3,606,573...3,625,991
Ensembl chrNW_004624857:3,606,431...3,627,063
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:plasma:
RGD
PMID:22206010
RGD:7483588
NCBI chrNW_004624754:15,929,414...15,943,637
G
Vwf
von Willebrand factor
ISO
protein:increased expression:plasma
RGD
PMID:16764036
RGD:1625709
NCBI chrNW_004624860:2,843,268...2,973,888
Ensembl chrNW_004624860:2,858,088...2,973,052
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all